Long-term Care Issues Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Long-term Care Issues. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Long-term Care Issues Indian Medical PG Question 1: Which of the following is a cognitive disorder?
- A. Dementia (Correct Answer)
- B. Intellectualization
- C. Depersonalization
- D. All of the options
Long-term Care Issues Explanation: ***Dementia***
- **Dementia** is a syndrome characterized by a significant decline in **cognitive function**, specifically in areas like memory, language, problem-solving, and reasoning.
- It impairs a person's ability to perform everyday activities and is caused by various diseases that damage brain cells, such as **Alzheimer's disease**.
*Intellectualization*
- **Intellectualization** is an **ego defense mechanism** where a person uses excessive abstract thinking and intellectual concepts to avoid confronting emotions or internal conflicts.
- While it involves thought processes, it is a psychological coping mechanism, not a cognitive disorder characterized by neurological impairment.
*Depersonalization*
- **Depersonalization** is a dissociative symptom characterized by a feeling of detachment from one's own body, thoughts, feelings, or actions, as if observing oneself from outside.
- It's a symptom of a **dissociative disorder** or other mental health conditions, not a disorder primarily defined by cognitive impairment in the way dementia is.
*All of the options*
- This option is incorrect because only dementia is classified as a primary **cognitive disorder**.
- Intellectualization and depersonalization are psychological phenomena or symptoms of other mental health conditions, not standalone cognitive disorders.
Long-term Care Issues Indian Medical PG Question 2: Which of the following is the most appropriate treatment for an overactive bladder in a patient with dementia?
- A. Tolterodine (Correct Answer)
- B. Mirabegron
- C. Behavioral therapy/bladder training
- D. Oxybutynin
- E. Trospium
Long-term Care Issues Explanation: ***Tolterodine***
- **Tolterodine** is a **muscarinic antagonist** that blocks acetylcholine receptors in the bladder, reducing detrusor muscle contractions and overactive bladder symptoms.
- Unlike some other anticholinergics like oxybutynin, it has a **lower propensity to cross the blood-brain barrier** and thus a reduced risk of exacerbating cognitive impairment in patients with dementia.
*Mirabegron*
- **Mirabegron** is a **beta-3 adrenergic agonist** that relaxes the detrusor muscle, increasing bladder capacity.
- While it has a different mechanism of action and is less likely to cause anticholinergic cognitive side effects than older anticholinergics, it can still cause **hypertension** and **tachycardia**, which may be problematic in elderly patients with comorbidities.
*Behavioral therapy/bladder training*
- **Behavioral therapy** and **bladder training** are important first-line treatments for overactive bladder.
- However, for patients with **dementia**, cognitive impairment often makes adherence to and understanding of these complex therapies challenging or impossible without significant caregiver support.
*Oxybutynin*
- **Oxybutynin** is an **anticholinergic drug** that is effective for overactive bladder.
- However, it has a **high affinity for muscarinic receptors** in the brain and readily crosses the blood-brain barrier, significantly increasing the risk of **cognitive impairment, confusion, and delirium** in elderly patients, especially those with pre-existing dementia.
*Trospium*
- **Trospium** is a **quaternary amine anticholinergic** that is hydrophilic and has minimal blood-brain barrier penetration.
- While theoretically safer than oxybutynin in terms of CNS effects, it has **lower bladder selectivity** compared to tolterodine and may cause more peripheral anticholinergic side effects (dry mouth, constipation).
Long-term Care Issues Indian Medical PG Question 3: Movement across socioeconomic levels is termed as:
- A. Social equality
- B. Social upliftment
- C. Social mobility (Correct Answer)
- D. Social insurance
Long-term Care Issues Explanation: ***Social mobility***
- This term refers to the **movement of individuals or groups** between different socioeconomic positions.
- It describes changes in **social status**, whether upward, downward, or horizontal, within a societal hierarchy.
*Social equality*
- This concept refers to a state where all individuals within a society have the **same rights, opportunities, and social status**, regardless of background.
- It specifically addresses fairness and justice in access to resources and treatment, rather than movement between social tiers.
*Social upliftment*
- This term generally refers to efforts or programs aimed at **improving the social and economic conditions** of disadvantaged groups or communities.
- While it can lead to upward social mobility, it specifically describes the *process of improvement* rather than the general concept of movement between levels.
*Social insurance*
- This refers to a system where contributions are made by individuals and employers to provide **financial protection** against various risks like unemployment, sickness, or old age.
- It is a specific type of social welfare program and does not describe the movement between socioeconomic levels.
Long-term Care Issues Indian Medical PG Question 4: All are true about dying declaration except
- A. Cross examination permitted (Correct Answer)
- B. Practiced in India
- C. Oath is not needed
- D. Made to Judicial Magistrate Or Medical officer
Long-term Care Issues Explanation: ***Cross-examination permitted***
- A **dying declaration** is an exception to the hearsay rule, and the declarant (the dying person) is **not available for cross-examination**, as they are deceased.
- The principle is based on the belief that a dying person would not lie, thus making cross-examination unnecessary for truthfulness in this context.
*Practiced in India*
- Dying declarations are indeed a recognized and practiced form of evidence in **Indian law**, specifically under Section 32(1) of the Indian Evidence Act, 1872.
- They are considered a significant piece of evidence in criminal proceedings, especially in cases of murder or culpable homicide.
*Oath is not needed*
- A dying declaration does **not require an oath** to be administered to the declarant at the time of making the statement.
- The belief that a person on the verge of death would speak the truth, known as the maxim **"nemo moriturus praesumitur mentiri"** (no one about to die is presumed to lie), substitutes the need for an oath.
*Made to Judicial Magistrate Or Medical officer*
- While a dying declaration can be made to **anyone**, including ordinary citizens, statements recorded by a **Judicial Magistrate** or a **Medical Officer** are generally given higher evidentiary value due to their impartiality and official capacity.
- A medical officer can attest to the declarant's **mental fitness** at the time of making the statement, which is crucial for its admissibility.
Long-term Care Issues Indian Medical PG Question 5: Dementia of Alzheimer's type is not associated with one of the following
- A. Delusions
- B. Apraxia and aphasia
- C. Cerebral infarcts (Correct Answer)
- D. Depressive symptoms
Long-term Care Issues Explanation: ***Cerebral infarcts***
- **Cerebral infarcts** are characteristic of **vascular dementia**, where brain damage is caused by reduced blood flow due to stroke or transient ischemic attacks.
- While an individual with Alzheimer's could coincidentally have a stroke, **cerebral infarcts** are not a primary neuropathological feature or an expected clinical association inherent to the progression of Alzheimer's disease itself.
*Delusions*
- **Delusions**, particularly paranoid delusions (e.g., believing caregivers are stealing from them), are relatively common **psychotic symptoms** that can occur in later stages of Alzheimer's disease.
- They are considered a behavioral and psychological symptom of dementia (BPSD) and can significantly impact the patient's and caregiver's quality of life.
*Apraxia and aphasia*
- **Apraxia** (difficulty with motor tasks despite intact motor function) and **aphasia** (language difficulties) are core **cognitive symptoms** that define Alzheimer's dementia.
- These are progressive deficits in executive function, language, and motor skills that lead to functional impairment.
*Depressive symptoms*
- **Depressive symptoms**, including apathy, anhedonia, and low mood, are highly prevalent in individuals with Alzheimer's disease, particularly in the earlier stages.
- They can be a reaction to the cognitive decline and loss of independence, or a direct result of the neurodegenerative process affecting mood-regulating brain regions.
Long-term Care Issues Indian Medical PG Question 6: Which of the following is a set point for plans but is something that cannot be quantified or measured?
- A. Target
- B. Objective
- C. Mission (Correct Answer)
- D. Goal
Long-term Care Issues Explanation: ***Mission***
- A **mission statement** defines an organization's fundamental purpose and values, guiding its actions and decisions.
- It describes **why an organization exists** and what it aims to achieve, but it is typically a broad, qualitative statement that cannot be directly measured.
*Target*
- A **target** is a specific, measurable result that an organization aims to achieve within a defined timeframe.
- Targets are quantifiable and used to track progress toward objectives and goals.
*Objective*
- An **objective** is a specific aim or desired outcome that an individual or organization plans to achieve.
- Objectives are typically quantifiable, time-bound, and measurable, providing clear criteria for success.
*Goal*
- A **goal** is a desired result or outcome that a person or system envisions, plans, and commits to achieve.
- While generally broader than objectives, goals are still typically **quantifiable** or at least verifiable, meaning their attainment can be assessed.
Long-term Care Issues Indian Medical PG Question 7: Rivastigmine & donepezil are drugs used predominantly in the management of ?
- A. Dissociation
- B. Dementia (Correct Answer)
- C. Delusions
- D. Depression
Long-term Care Issues Explanation: ***Dementia***
- **Rivastigmine** and **donepezil** are **acetylcholinesterase inhibitors** that increase acetylcholine levels in the brain.
- This mechanism is primarily used to improve **cognitive function** in patients with **Alzheimer's disease** and other forms of dementia.
*Dissociation*
- Dissociation involves a mental process causing a lack of connection between thoughts, memory, and identity, and is not typically treated with cholinesterase inhibitors.
- Management often involves **psychotherapy** and sometimes anti-anxiety medications or antidepressants, if comorbid conditions are present.
*Delusions*
- Delusions are fixed, false beliefs often associated with psychotic disorders like **schizophrenia** or severe mood disorders.
- Treatment primarily involves **antipsychotic medications**, not acetylcholinesterase inhibitors.
*Depression*
- Depression is a mood disorder characterized by persistent sadness and loss of interest.
- It is typically treated with **antidepressants** (e.g., SSRIs, SNRIs), psychotherapy, or lifestyle changes, none of which include rivastigmine or donepezil.
Long-term Care Issues Indian Medical PG Question 8: Regarding Alzheimer's disease which is/are not true :
- A. Initial loss of long term memory
- B. Step ladder pattern
- C. Delayed loss of short term memory
- D. All of the options (Correct Answer)
Long-term Care Issues Explanation: ***Correct Option: All of the options***
- All three statements provided are **incorrect descriptions** of Alzheimer's disease.
- In Alzheimer's disease, **short-term memory loss occurs early** (not delayed), **long-term memory is preserved initially** (not lost first), and progression is **gradual and continuous** (not step-ladder pattern).
- Since all the statements are "not true" about Alzheimer's, "All of the options" is the correct answer to this negatively worded question.
*Incorrect Statement: Initial loss of long term memory*
- This is **NOT TRUE** for Alzheimer's disease.
- Alzheimer's is characterized by **early impairment of short-term memory** (new memory formation).
- Patients struggle to recall recent events or learn new information, while **long-term memories from the past** are preserved until later stages.
- Remote memories (childhood, early adulthood) remain relatively intact in early-to-moderate disease.
*Incorrect Statement: Step ladder pattern*
- This is **NOT TRUE** for Alzheimer's disease.
- Alzheimer's progression is typically **gradual, insidious, and continuous** with steady cognitive decline.
- A **step-ladder (stepwise) pattern** with sudden declines followed by plateaus is characteristic of **vascular dementia**, resulting from multiple cerebrovascular events.
- The stepwise deterioration reflects discrete vascular insults, not the neurodegenerative process of Alzheimer's.
*Incorrect Statement: Delayed loss of short term memory*
- This is **NOT TRUE** for Alzheimer's disease.
- **Short-term memory loss** is one of the **earliest and most prominent symptoms** of Alzheimer's disease, not delayed.
- Classic early presentations include difficulty recalling recently learned information, forgetting appointments, repeating questions, and misplacing items.
- The hippocampus, critical for forming new memories, is affected early in the disease process.
Long-term Care Issues Indian Medical PG Question 9: Which of the following antidepressants can be safely used in elderly depression?
- A. Trazodone
- B. Mianserin (Correct Answer)
- C. Fluoxetine
- D. Phenelzine
Long-term Care Issues Explanation: In geriatric psychiatry, the choice of antidepressant is dictated by the side-effect profile, specifically the risk of anticholinergic effects, sedation, and cardiovascular complications.
**Why Mianserin is correct:**
Mianserin is a tetracyclic antidepressant (TeCA) that is frequently preferred in the elderly because it lacks significant **anticholinergic side effects** (which cause confusion, urinary retention, and glaucoma) and has minimal **cardiotoxicity**. It is particularly useful in elderly patients with insomnia or agitation due to its sedative properties, but it does not typically cause the severe orthostatic hypotension seen with older TCAs.
**Analysis of Incorrect Options:**
* **Fluoxetine (Option C):** While SSRIs are first-line for the elderly, Fluoxetine has a very **long half-life** (and active metabolites) which can lead to accumulation and prolonged side effects (like hyponatremia/SIADH or agitation) in patients with age-related renal or hepatic decline. Sertraline is generally preferred over Fluoxetine in this age group.
* **Trazodone (Option A):** Though used for sleep, it is notorious for causing significant **orthostatic hypotension** in the elderly, increasing the risk of falls and hip fractures.
* **Phenelzine (Option D):** As a non-selective MAOI, it requires strict dietary restrictions and carries a high risk of **hypertensive crisis** and drug-drug interactions, making it unsafe for the polypharmacy often seen in geriatric patients.
**NEET-PG High-Yield Pearls:**
* **Drug of Choice:** SSRIs (specifically **Sertraline** or **Escitalopram**) are generally the first-line treatment for elderly depression.
* **Mianserin Risk:** Always monitor for **agranulocytosis** (rare but serious).
* **Avoid:** Tertiary amines (Amitriptyline, Imipramine) due to high anticholinergic activity.
* **Key Concern:** Always check for **hyponatremia** (SIADH) when starting an SSRI in an elderly patient.
Long-term Care Issues Indian Medical PG Question 10: "Sundowning" is seen in which of the following conditions?
- A. Night blindness
- B. Parkinsonism
- C. Delirium (Correct Answer)
- D. Solar urticaria
Long-term Care Issues Explanation: **Explanation:**
**Sundowning** refers to a clinical phenomenon characterized by the emergence or worsening of neuropsychiatric symptoms—such as agitation, confusion, anxiety, and aggressiveness—specifically during the late afternoon or evening hours.
**Why Delirium is the Correct Answer:**
Sundowning is most commonly associated with **Delirium** and **Dementia** (particularly Alzheimer’s disease). It occurs due to a combination of factors: the loss of daylight (fading circadian cues), sensory deprivation in low light, and accumulated fatigue throughout the day. In patients with pre-existing cognitive impairment, the brain's ability to process environmental stimuli diminishes as light levels drop, leading to acute disorientation and behavioral disturbances.
**Analysis of Incorrect Options:**
* **A. Night blindness:** This is a physiological inability to see in low light (often due to Vitamin A deficiency) and does not involve the cognitive or behavioral agitation seen in sundowning.
* **B. Parkinsonism:** While Parkinson’s patients may experience sleep disturbances or dementia-related confusion, sundowning is not a hallmark feature of the motor syndrome itself.
* **D. Solar urticaria:** This is a physical dermatological condition (hives) triggered by exposure to ultraviolet radiation, the opposite of the "diminishing light" trigger of sundowning.
**High-Yield Clinical Pearls for NEET-PG:**
* **Management:** The first step in managing sundowning is optimizing the environment (e.g., keeping the room well-lit during the evening, reducing noise, and maintaining a strict routine).
* **Differential:** Always rule out a "Medical Delirium" (UTI, electrolyte imbalance) if sundowning symptoms appear suddenly.
* **Pharmacology:** If behavioral interventions fail, low-dose atypical antipsychotics (like Quetiapine) or Melatonin may be considered, though they are secondary to environmental modification.
More Long-term Care Issues Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
